Chembio Diagnostics, Inc. (CEMI)
CEMIPrice: $0.46
Fair Value: 🔒
🔒score
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue... more
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercialize... more
Description
Shares
| Market Cap | $16.71M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Richard L. Eberly |
| IPO Date | 2000-10-18 | CAGR | — |
| Employees | 188 | Website | chembio.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
CEMI chart loading...
Fundamentals
Technicals
| Enterprise Value | $12.24M | P/E Ratio | -0.63 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 0.35 | P/B Ratio | 0.62 |
| P/CF Ratio | -0.87 | P/FCF Ratio | -1.18 |
| EPS | $-0.72 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 30.91% | Gross Margin | 0.2% |
| Operating Margin | -0.42% | Profit Margin | -0.48% |
| ROE | -0.89% | ROA | -0.37% |
| ROCE | -0.88% | Current Ratio | 1.23 |
| Quick Ratio | 1.04 | Cash Ratio | 0.46 |
| Debt/Equity | 1.41 | Interest Coverage | -53.41 |
| Altman Z Score | -3.35 | Piotroski Score | 5 |